Logo

People in the News: Apr 16, 2009

Apr 16, 2009
Premium

Santaris Pharma has appointed Arthur Levin, its chief development officer, as president of its new California-based subsidiary.

Levin previously served as vice president of drug development at Isis Pharmaceuticals. He holds a PhD in toxicology from the University of Rochester School of Medicine and Dentistry.

Filed under

Gene Silencing/Gene Editing
Drug Discovery & Development
RNAi
drug development
Isis
Breaking News
The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.